Global Health (MEDANTA) | Financial Analysis & Statements
Global Health Ltd. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.3B
Gross Profit
7.9B
76.81%
Operating Income
1.8B
17.64%
Net Income
1.6B
15.42%
EPS (Diluted)
₹5.91
Balance Sheet Metrics
Total Assets
47.7B
Total Liabilities
13.8B
Shareholders Equity
33.9B
Debt to Equity
0.41
Cash Flow Metrics
Operating Cash Flow
1.4B
Free Cash Flow
828.7M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Global Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 36.4B | 32.4B | 26.8B | 21.7B | 14.3B |
| Cost of Goods Sold | 8.8B | 7.6B | 6.3B | 5.4B | 3.5B |
| Gross Profit | 27.6B | 24.8B | 20.6B | 16.2B | 10.8B |
| Gross Margin % | 75.8% | 76.6% | 76.7% | 74.9% | 75.6% |
| Operating Expenses | |||||
| Research & Development | 4.1M | 420.0K | 340.0K | 590.0K | 270.0K |
| Selling, General & Administrative | 6.0B | 5.3B | 4.2B | 2.4B | 294.6M |
| Other Operating Expenses | 3.8B | 3.5B | 3.1B | 3.7B | 3.5B |
| Total Operating Expenses | 9.9B | 8.8B | 7.3B | 6.0B | 3.8B |
| Operating Income | 7.4B | 6.7B | 5.0B | 3.2B | 927.0M |
| Operating Margin % | 20.3% | 20.6% | 18.6% | 15.0% | 6.5% |
| Non-Operating Items | |||||
| Interest Income | 703.2M | 596.8M | 355.4M | 167.2M | 177.6M |
| Interest Expense | 640.2M | 725.4M | 774.6M | 794.9M | 671.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 6.5B | 6.3B | 4.5B | 2.8B | 324.6M |
| Income Tax | 1.7B | 1.5B | 1.2B | 843.6M | 36.6M |
| Effective Tax Rate % | 25.6% | 23.8% | 27.4% | 30.1% | 11.3% |
| Net Income | 4.8B | 4.8B | 3.3B | 2.0B | 288.0M |
| Net Margin % | 13.2% | 14.8% | 12.2% | 9.1% | 2.0% |
| Key Metrics | |||||
| EBITDA | 10.0B | 9.0B | 6.8B | 4.9B | 2.3B |
| EPS (Basic) | ₹17.92 | ₹17.80 | ₹12.58 | ₹7.75 | ₹1.15 |
| EPS (Diluted) | ₹17.92 | ₹17.80 | ₹12.57 | ₹7.73 | ₹1.14 |
| Basic Shares Outstanding | 268607382 | 268607382 | 259208847 | 253236430 | 251408994 |
| Diluted Shares Outstanding | 268607382 | 268607382 | 259208847 | 253236430 | 251408994 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Global Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.3B | 4.2B | 7.7B | 1.2B | 694.7M |
| Short-term Investments | 8.2B | 7.3B | 4.9B | 3.9B | 2.2B |
| Accounts Receivable | 2.9B | 2.2B | 1.9B | 1.8B | 1.3B |
| Inventory | 671.4M | 668.5M | 603.7M | 533.9M | 397.6M |
| Other Current Assets | 189.9M | 168.6M | 141.3M | 41.5M | - |
| Total Current Assets | 15.3B | 15.1B | 15.8B | 8.1B | 5.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 15.1B | 13.1B | 11.3B | 9.9B | 8.1B |
| Goodwill | 112.8M | 55.4M | 51.7M | 62.7M | 72.4M |
| Intangible Assets | 112.8M | 55.4M | 51.7M | 62.7M | 72.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 512.6M | 173.1M | 10.0K | - | - |
| Total Non-Current Assets | 32.3B | 28.0B | 25.4B | 23.3B | 21.9B |
| Total Assets | 47.7B | 43.0B | 41.2B | 31.5B | 26.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.9B | 1.9B | 1.9B | 1.3B | 1.3B |
| Short-term Debt | 942.3M | 1.7B | 1.4B | 1.1B | 1.0B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 609.2M | 28.6M | 189.9M | 23.7M | 14.1M |
| Total Current Liabilities | 6.2B | 6.2B | 5.7B | 4.2B | 4.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 6.2B | 6.3B | 9.8B | 10.0B | 8.3B |
| Deferred Tax Liabilities | 0 | 241.6M | 188.1M | 0 | 0 |
| Other Non-Current Liabilities | 221.2M | 480.0K | 468.4M | - | - |
| Total Non-Current Liabilities | 7.6B | 7.8B | 11.2B | 11.1B | 9.1B |
| Total Liabilities | 13.8B | 14.0B | 16.9B | 15.3B | 13.1B |
| Equity | |||||
| Common Stock | 537.2M | 537.0M | 536.4M | 506.4M | 495.9M |
| Retained Earnings | 22.5B | 17.6B | 12.8B | 9.5B | 7.7B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 33.9B | 29.1B | 24.3B | 16.2B | 13.8B |
| Key Metrics | |||||
| Total Debt | 7.2B | 8.0B | 11.2B | 11.1B | 9.3B |
| Working Capital | 9.1B | 8.9B | 10.1B | 3.9B | 974.7M |
Balance Sheet Composition
Global Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 6.5B | 6.3B | 4.5B | 2.8B | 324.6M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 0 | 1.6M | 7.5M | 17.4M | 37.9M |
| Working Capital Changes | -1.3B | -549.0M | 424.6M | -518.7M | 357.8M |
| Operating Cash Flow | 5.4B | 5.7B | 5.2B | 2.8B | 1.0B |
| Investing Activities | |||||
| Capital Expenditures | -5.1B | -2.8B | -2.4B | -2.7B | -1.4B |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -44.9M | - | -1.4B | -1.7B | -1.2B |
| Investment Sales | - | - | - | 83.7M | 50.4M |
| Investing Cash Flow | -6.6B | -5.2B | -5.0B | -4.4B | -2.5B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 1.5B | 1.4B | 390.8M | 2.4B | 0 |
| Debt Repayment | -1.8B | -5.8B | -666.5M | -198.9M | -30.2M |
| Financing Cash Flow | -435.5M | -4.5B | 4.5B | 2.5B | -28.6M |
| Free Cash Flow | -241.6M | 3.3B | 4.1B | 367.9M | 960.3M |
| Net Change in Cash | -1.6B | -3.9B | 4.7B | 992.6M | -1.5B |
Cash Flow Trend
Global Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
58.23
Forward P/E
43.09
Price to Book
8.08
Price to Sales
7.15
PEG Ratio
-1.74
Profitability Ratios
Profit Margin
12.29%
Operating Margin
13.93%
Return on Equity
14.21%
Return on Assets
10.10%
Financial Health
Current Ratio
2.40
Debt to Equity
25.47
Beta
-0.02
Per Share Data
EPS (TTM)
₹19.12
Book Value per Share
₹137.83
Revenue per Share
₹155.73
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MEDANTA | 298.6B | 58.23 | 8.08 | 14.21% | 12.29% | 25.47 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Fortis Healthcare | 699.7B | 72.46 | 7.40 | 8.44% | 10.94% | 32.96 |
| Narayana Hrudayalaya | 365.2B | 46.80 | 8.99 | 21.78% | 11.49% | 57.61 |
| Aster DM Healthcare | 364.6B | 110.37 | 8.03 | 147.28% | 7.33% | 43.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.





